Therapeutic interventions should be orientated on those biochemical indices that indicate a safe GH/IGF-1 concentration, as data on complete remission or even cure of acromegaly are still highly controversial due to problems of assay technologies and standardisation. This evidence concerns the gene GH1 and acromegaly.